CN102654503A - Method for detecting influence of attenuation bacillus calmette-guerin to asthma - Google Patents

Method for detecting influence of attenuation bacillus calmette-guerin to asthma Download PDF

Info

Publication number
CN102654503A
CN102654503A CN2011100517847A CN201110051784A CN102654503A CN 102654503 A CN102654503 A CN 102654503A CN 2011100517847 A CN2011100517847 A CN 2011100517847A CN 201110051784 A CN201110051784 A CN 201110051784A CN 102654503 A CN102654503 A CN 102654503A
Authority
CN
China
Prior art keywords
asthma
attenuated live
bcg vaccine
live bcg
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011100517847A
Other languages
Chinese (zh)
Inventor
张雅琴
眭建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Vocational Health College
Original Assignee
Suzhou Vocational Health College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Vocational Health College filed Critical Suzhou Vocational Health College
Priority to CN2011100517847A priority Critical patent/CN102654503A/en
Publication of CN102654503A publication Critical patent/CN102654503A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a method for detecting influences of attenuation bacillus calmette-guerin to asthma. The method comprises the following steps of: establishing asthma models of animals, inoculating bacillus calmette-guerin many times, and detecting the expression of lung tissue TLR4 (toll-like receptor 4) of the small animals by western blotting. According to the method for detecting influences of attenuationbacillus calmette-guerin to asthma of the invention, the influences of attenuation bacillus calmette-guerin to asthma are as follows: the therapeutic effects of the bacillus calmette-guerin are relative to the enhancement of the TLR4 (toll-like receptor 4) of the lung tissue, so that the attenuation bacillus calmette-guerin can play an important function in treating the asthma.

Description

A kind of attenuated live BCG vaccine is to the detection method of asthma influence
Technical field
The present invention relates to medical domain, be specifically related to the detection method of a kind of attenuated live BCG vaccine the asthma influence.
Background technology
Asthma has airway hyperreactivity, Ig-E regulates and the specific reaction gene.Toll appearance acceptor be in mammal, find with fruit bat the albumen of homology is arranged, called after TLR, the initial TLR4 that finds is that research is maximum at present.Research confirms; Its mycobacterium lipoprotein of attenuated live BCG vaccine can with Toll appearance receptors bind on the macrophage; Promote macrophage to produce IL-12, IFN-γ, suppress the generation of IL-4, IL-5, thus correct in the asthma Th1/Th2 subgroup number with (or) functional imbalance.
At present, the attenuated live BCG vaccine is also unknown to the influence that asthma TLR4 expresses.
Summary of the invention
The object of the present invention is to provide the detection method of a kind of attenuated live BCG vaccine to the asthma influence, having solved present attenuated live BCG vaccine influences the problem that does not also have corresponding detecting method to asthma.
A kind of attenuated live BCG vaccine of the present invention is to the detection method of asthma influence, and concrete steps are:
Step 1) preparing experiment animal and reagent: preparing experiment is with the mouse IgG antibody of toy, ovalbumin, attenuated live BCG vaccine, anti-TLR4 monoclonal antibody, anti-GAPDH monoclonal antibody and HRP mark;
Step 2) grouping of animal used as test and sensitization model preparation: the experiment toy is divided into three groups that the toy number of elements equates at random, is respectively blank group, asthma morbidity group and attenuated live BCG vaccine intervention group,
Asthma morbidity group: 1st, 7,14 days lumbar injection egg albumen sensitizations, with Al (OH) 3As immunologic adjuvant, began atomizing on the 15th day and excite, set up asthmatic model;
Attenuated live BCG vaccine intervention group: the foundation of asthmatic model is with asthma morbidity group, excites with last atomizing preceding 1 day of each sensitization and carries out the intracutaneous injection of attenuated live BCG vaccine in 1 hour;
The blank group: use the physiologic saline for substitute ovalbumin,
All toys obtain sample after exciting 24h the last time;
The Western Blotting of step 3) toy lung tissue TLR4 albumen detects: get each group experiment toy lung tissue and extract total protein, measure concentration.Behind each histone sample SDS-PAGE electrophoresis, electrotransfer is to pvdf membrane; Pvdf membrane is behind sealing 2h, with the TLR4 monoclonal antibody after the dilution, incubated overnight; Again further with two anti-hatching of horseradish peroxidase after, drip chemical luminous substrate, x-ray film sensitization detects protein signal;
The step 4) data statistics: all experimental results are carried out statistical study.
Preferably, said step 2) in, the concentration of the egg albumen sensitization of injection is 0.08%, injection volume is 0.2ml.
Preferably, said step 2) in, the each dosage of attenuated live BCG vaccine intracutaneous injection is 0.025mg.
Preferably, in the said step 3), the temperature of incubated overnight is 4 ℃.
Preferably, in the said step 4), what the statistical study of experimental result was adopted is SPSS10.0 software.。
Beneficial effect: through the detection method of attenuated live BCG vaccine of the present invention to the asthma influence; Analysis draws; Because TLR4 albumen only has the expression of trace in the lung tissue of blank group; The expression of TLR4 albumen slightly raises than control group in the asthma morbidity group, and the expression of TLR4 albumen all has significant enhancing for more preceding two groups in the attenuated live BCG vaccine intervention group, and the attenuated live BCG vaccine possibly be through stimulating the TLR4 up-regulated; And then regulate the Th1/Th2 balance, in the treatment of asthma morbidity, play a significant role.
Embodiment
Embodiment 1
1 materials and methods
1) preparation of animal used as test and reagent
The mouse IgG antibody of Kunming kind small white mouse, ovalbumin, attenuated live BCG vaccine, anti-TLR4 monoclonal antibody, anti-GAPDH monoclonal antibody, HRP mark etc.
2) grouping of animal used as test and sensitization model preparation
Animal used as test is divided into three groups at random, is respectively blank group, asthma morbidity group and attenuated live BCG vaccine intervention group, every group of 10 mouse.Asthma morbidity group: 1st, 7,14 days lumbar injection 0.08%OVA sensitization, each 0.2ml, Al (OH) 3As immunologic adjuvant.Beginning atomizing on the 15th day excites; Attenuated live BCG vaccine intervention group: the foundation of asthmatic model is with asthma morbidity group, excites in 1 hour the intracutaneous injection of attenuated live BCG vaccine to intervene once more in preceding 1 day of each sensitization and last atomizing, and each dosage is 0.025mg; Blank group: use physiologic saline for substitute OVA.All mouse obtain sample after exciting 24h the last time.
3) the Western Blotting of mouse lung tissue T LR4 albumen detects
Get and respectively organize experiment mice lung tissue extraction total protein, measure concentration.Behind each histone sample SDS-PAGE electrophoresis, electrotransfer is to pvdf membrane.Pvdf membrane is behind sealing 2h, with the TLR4 monoclonal antibody after the dilution, 4 ℃ of incubated overnight.Again further with two anti-hatching of horseradish peroxidase after, drip chemical luminous substrate, x-ray film sensitization detects protein signal.
4) data statistics
All experimental results adopt SPSS10.0 software to carry out statistical study, and the result representes with the form of .Group difference adopts the t check.
2 results
TLR4 albumen only has the expression of trace in the lung tissue of blank group, the expression of TLR4 albumen slightly raises than control group in the asthma morbidity group, and the expression of TLR4 albumen all has significant enhancing for more preceding two groups in the attenuated live BCG vaccine intervention group.
3. conclusion
The attenuated live BCG vaccine is the attenuated live vaccine of tubercle bacillus, and its principal ingredient is a BCG vaccine RNA..Research confirms, after the part of TLR4 combines TLR4, through striding membrane structure the pathogen-associated molecular stimulus signal transduceed in the cell, produces complicated cascade signal reaction.
Find that through experiment the TLR4 gene expression amount is compared with blank group and asthma morbidity group all has remarkable rising after the attenuated live BCG vaccine is intervened.The attenuated live BCG vaccine possibly be through stimulation TLR4 up-regulated, and then regulates the Th1/Th2 balance, in the treatment of asthma morbidity, plays a significant role.

Claims (5)

1. an attenuated live BCG vaccine is characterized in that to the detection method that asthma influences concrete steps are:
1) preparing experiment animal and reagent: preparing experiment is with the mouse IgG antibody of toy, ovalbumin, attenuated live BCG vaccine, anti-TLR4 monoclonal antibody, anti-GAPDH monoclonal antibody and HRP mark;
2) grouping of animal used as test and sensitization model preparation: the experiment toy is divided into three groups that the toy number of elements equates at random, is respectively blank group, asthma morbidity group and attenuated live BCG vaccine intervention group,
Asthma morbidity group: 1st, 7,14 days lumbar injection egg albumen sensitizations, with Al (OH) 3As immunologic adjuvant, began atomizing on the 15th day and excite, set up asthmatic model;
Attenuated live BCG vaccine intervention group: the foundation of asthmatic model is with asthma morbidity group, excites with last atomizing preceding 1 day of each sensitization and carries out the intracutaneous injection of attenuated live BCG vaccine in 1 hour;
The blank group: use the physiologic saline for substitute ovalbumin,
All toys obtain sample after exciting 24h the last time;
3) the Western Blotting of toy lung tissue TLR4 albumen detects: get each group experiment toy lung tissue and extract total protein, measure concentration.Behind each histone sample SDS-PAGE electrophoresis, electrotransfer is to pvdf membrane; Pvdf membrane is behind sealing 2h, with the TLR4 monoclonal antibody after the dilution, incubated overnight; Again further with two anti-hatching of horseradish peroxidase after, drip chemical luminous substrate, x-ray film sensitization detects protein signal;
4) data statistics: all experimental results are carried out statistical study.
2. attenuated live BCG vaccine according to claim 1 is characterized in that said step 2 to the detection method of asthma influence) in, the concentration of the egg albumen sensitization of injection is 0.08%, injection volume is 0.2ml.
3. attenuated live BCG vaccine according to claim 1 is characterized in that said step 2 to the detection method of asthma influence) in, the each dosage of attenuated live BCG vaccine intracutaneous injection is 0.025mg.
4. attenuated live BCG vaccine according to claim 1 is characterized in that to the detection method of asthma influence in the said step 3), the temperature of incubated overnight is 4 ℃.
5. attenuated live BCG vaccine according to claim 1 is characterized in that the detection method of asthma influence, and in the said step 4), what the statistical study of experimental result was adopted is SPSS10.0 software.
CN2011100517847A 2011-03-04 2011-03-04 Method for detecting influence of attenuation bacillus calmette-guerin to asthma Pending CN102654503A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100517847A CN102654503A (en) 2011-03-04 2011-03-04 Method for detecting influence of attenuation bacillus calmette-guerin to asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100517847A CN102654503A (en) 2011-03-04 2011-03-04 Method for detecting influence of attenuation bacillus calmette-guerin to asthma

Publications (1)

Publication Number Publication Date
CN102654503A true CN102654503A (en) 2012-09-05

Family

ID=46730159

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100517847A Pending CN102654503A (en) 2011-03-04 2011-03-04 Method for detecting influence of attenuation bacillus calmette-guerin to asthma

Country Status (1)

Country Link
CN (1) CN102654503A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138436A1 (en) * 1998-10-05 2003-07-24 The Malaghan Institute Of Medical Research Method of using a vaccine
CN101069743A (en) * 2004-07-27 2007-11-14 张锦铭 Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
JP2009014626A (en) * 2007-07-06 2009-01-22 Medibic:Kk Method of predicting bcg therapy effect
CN101813631A (en) * 2010-03-26 2010-08-25 浙江万马药业有限公司 BCG polyose nuclear acid injection polysaccharide rapid determination method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030138436A1 (en) * 1998-10-05 2003-07-24 The Malaghan Institute Of Medical Research Method of using a vaccine
CN101069743A (en) * 2004-07-27 2007-11-14 张锦铭 Use of inactive BCG vaccine in preparation of use for treatment of allergic action diseases
JP2009014626A (en) * 2007-07-06 2009-01-22 Medibic:Kk Method of predicting bcg therapy effect
CN101813631A (en) * 2010-03-26 2010-08-25 浙江万马药业有限公司 BCG polyose nuclear acid injection polysaccharide rapid determination method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
张雅琴等: "减毒活菌卡介苗对哮喘TLR4表达的影响", 《中国实用医药》, vol. 35, no. 5, 31 December 2010 (2010-12-31) *
易丽等: "活菌卡介苗对哮喘小鼠IL-17的调节作用", 《热带医学杂志》, vol. 11, no. 4, 30 April 2011 (2011-04-30) *
王鹏等: "卵白蛋白致敏时减毒活菌卡介苗干预对哮喘小鼠气道炎性反应的影响", 《武警医学》, vol. 22, no. 7, 31 July 2011 (2011-07-31) *

Similar Documents

Publication Publication Date Title
Cheng et al. Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2
Park et al. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine
Icardi et al. Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system
CN106176799A (en) A kind of sulfated fucan is as the application of immunostimulant
CN104257671A (en) Construction method for mouse type 2 diabetes mellitus (T2DM) animal experiment model
CN101289496A (en) Epitope screening method capable of exciting anti-mycobacterium tuberculosis protective immunological reaction of body and uses
Karlsson et al. Influence of obesity on the response to influenza infection and vaccination
Vita et al. Physical activity and post-transcriptional regulation of Aging Decay: modulation of pathways in postmenopausal osteoporosis
CN109820844A (en) Spermidine is preparing the application in slimming medicine
Zhang et al. Astragalus on the anti-fatigue effect in hypoxic mice
Romanò et al. Persistence of immunity 18–19 years after vaccination against hepatitis B in 2 cohorts of vaccinees primed as infants or as adolescents in Italy
Lin et al. Phosphorylation of Radix Cyathula officinalis polysaccharide improves its immune-enhancing activity
Zhang et al. Effect of edible fungal polysaccharides on improving influenza vaccine protection in mice
Wu et al. Cordyceps improves obesity and its related inflammation via modulation of Enterococcus cecorum abundance and bile acid metabolism
Ikewaki et al. Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management
CN102654503A (en) Method for detecting influence of attenuation bacillus calmette-guerin to asthma
Liu et al. Astragaloside IV Alleviates Depression in Rats by Modulating Intestinal Microbiota, T-Immune Balance, and Metabolome
Gurbuz et al. Effects of adding yeast cell walls and Yucca schidigera extract to diets of layer chicks
Han et al. Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice
Xi et al. Effects of ultrafine powder of the stem and leaf of Astragalus on immunity in chickens
CN103877596A (en) Establishment method of animal model for evaluating IPV (inactivated poliovirus vaccine) intradermal immunization effectiveness
Liu et al. Flavonoids from Radix Tetrastigmae improve LPS-induced acute lung injury via the TLR4/MD-2-mediated pathway
Chen et al. A Qualitative Analysis of Cultured Adventitious Ginseng Root’s Chemical Composition and Immunomodulatory Effects
Ma et al. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats
Nan et al. Effects of Lycium barbarum polysaccharides (LBP) on immune function of mice

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120905